NCT07667361

Brief Summary

  1. 1.Background \& Context
  2. 2.Study Objectives
  3. 3.Study Design \& Methods
  4. 4.Statistical Analysis

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
222

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Jan 2027

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2027

Expected
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

June 25, 2026

Status Verified

June 1, 2026

Enrollment Period

12 months

First QC Date

June 18, 2026

Last Update Submit

June 18, 2026

Conditions

Prediabetes

Keywords

life style habitsprediabetistime to habit formation

Outcome Measures

Primary Outcomes (1)

  • Time to Habit Adoption

    12 weeks

Study Arms (2)

Group A

EXPERIMENTAL
Other: Hybrid digital intervention with personalized support.

Group B

ACTIVE COMPARATOR
Other: Standard lifestyle education

Interventions

Standard lifestyle educationOTHER

Standard lifestyle education for12 weeks

Group B
Hybrid digital intervention with personalized support.OTHER

12 Weeks

Group A

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults(18-65 years) Risk of Diabetis

You may not qualify if:

  • Dignosed diabetis Pregnancy Any other contraindication to exericse praticipation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Shibili Nuhmani, PhD

CONTACT

00966554270531snuhmani@iau.edu.sa

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 18, 2026

First Posted

June 25, 2026

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

June 30, 2028

Last Updated

June 25, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share